Phase I Study of CPI-300 in Patients With Advanced Tumors
Clinical trial NCT04808453 · COMPLETED
Trial details
- NCT number
- NCT04808453
- Sponsor
- Coordination Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-15
- Primary completion
- 2023-12-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.